首页> 外文OA文献 >Effects of Nonsteroidal Anti-Inflammatory Drugs on Helicobacter pylori-Infected Gastric Mucosae of Mice: Apoptosis, Cell Proliferation, and Inflammatory Activity
【2h】

Effects of Nonsteroidal Anti-Inflammatory Drugs on Helicobacter pylori-Infected Gastric Mucosae of Mice: Apoptosis, Cell Proliferation, and Inflammatory Activity

机译:非甾体类抗炎药对幽门螺杆菌感染的小鼠胃粘膜的影响:细胞凋亡,细胞增殖和炎症活性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Helicobacter pylori and nonsteroidal anti-inflammatory drugs (NSAIDs) are two well-known important causative factors of gastric damage. While H. pylori increases apoptosis and the proliferation of gastric epithelial cells and is an important factor in peptic ulcer and gastric cancer, NSAIDs induce cell apoptosis and have antineoplastic effects. We investigated the effects of NSAIDs (a nonselective cyclooxygenase [COX] inhibitor [indomethacin] and a selective COX-2 inhibitor [NS-398]) on the apoptosis and proliferation of gastric epithelial cells and gastric inflammation in H. pylori-infected mice. C57BL/6 mice were sacrificed 8 weeks after H. pylori SS1 inoculation. Indomethacin (2 mg/kg) or NS-398 (10 mg/kg) was administered subcutaneously once daily for 10 days before sacrifice. The following were assessed: gastric inflammatory activity, gastric COX protein expression by Western blotting; gastric prostaglandin E2 levels by enzyme immunoassay, apoptosis by terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling, and cell proliferation by Ki67 immunostaining. Compared to the controls, H. pylori infection and/or NSAID treatment increased COX-1 and COX-2 protein expression. Gastric prostaglandin E2 levels, apoptotic index, cell proliferation index, neutrophil activity, and the degree of chronic inflammation were all increased by H. pylori infection, and these effects were significantly decreased by indomethacin treatment. However, NS-398 treatment after H. pylori infection did not induce a significant reduction, although it did result in a tendency to decrease. These results show that NSAIDs can reverse the increased apoptosis and proliferation of epithelial cells and inflammatory activity in the stomachs of H. pylori-infected mice and that, like COX-2 activation, COX-1 induction contributes to the change of gastric mucosal cell turnover and inflammation induced by H. pylori infection.
机译:幽门螺杆菌和非甾体类抗炎药(NSAIDs)是引起胃损害的两个众所周知的重要原因。幽门螺杆菌会增加细胞凋亡和胃上皮细胞的增殖,是消化性溃疡和胃癌的重要因素,而非甾体抗炎药会诱导细胞凋亡并具有抗肿瘤作用。我们研究了NSAIDs(一种非选择性环氧合酶[COX]抑制剂[indomethacin]和一种选择性COX-2抑制剂[NS-398])对幽门螺杆菌感染小鼠胃上皮细胞凋亡和增殖以及胃部炎症的影响。幽门螺杆菌SS1接种8周后处死C57BL / 6小鼠。在处死前,每天一次皮下注射消炎痛(2 mg / kg)或NS-398(10 mg / kg)。通过Western印迹评估以下内容:胃炎活性,胃COX蛋白表达;通过酶免疫法测定胃中前列腺素E2的水平,通过末端脱氧核苷酸转移酶介导的dUTP缺口末端标记进行凋亡,并通过Ki67免疫染色进行细胞增殖。与对照相比,幽门螺杆菌感染和/或NSAID治疗可增加COX-1和COX-2蛋白的表达。幽门螺杆菌感染可增加胃中前列腺素E2水平,细胞凋亡指数,细胞增殖指数,中性粒细胞活性和慢性炎症程度,而吲哚美辛治疗可明显降低这些作用。但是,幽门螺杆菌感染后的NS-398治疗虽然没有导致减少的趋势,但并未引起明显的减少。这些结果表明,NSAIDs可以逆转幽门螺杆菌感染小鼠的胃中上皮细胞凋亡和增殖的增加以及炎症活动,并且像COX-2激活一样,COX-1诱导也有助于改变胃黏膜细胞更新和幽门螺杆菌感染引起的炎症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号